Sinobioway Bio-medicine to Raise $300 Million for New CDMO Plant, an Industrial Info Market Brief
Sinobioway Bio-medicine to Raise $300 Million for New CDMO Plant, an Industrial Info Market Brief
Attachment: 20190813
Sinobioway Bio-medicine is looking for an engineering, procurement and construction (EPC) firm for a $300 million contract developing and manufacturing organization (CDMO) complex. The company plans to expand its active pharmaceutical ingredients and preparations market by building a grassroot complex in Hefei city of Anhui in China. Currently, the project is in a planning and scheduling stage; however, the company hopes to begin the site preparation work by the end of 2019, and operation is likely to commence in early 2021.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Canadian Oil & Gas Market Expected to See Heavy Investment from Asia
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...